SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-098429
Filing Date
2021-07-30
Accepted
2021-07-30 20:23:14
Documents
1
Period of Report
2021-07-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2123737d8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2123737d8_4seq1.xml 4 6067
  Complete submission text file 0001104659-21-098429.txt   7568
Mailing Address C/O HOLLIS-EDEN PHARMACEUTICALS 4435 EASTGATE MALL STE.400 SAN DIEGO CA 92121
Business Address
BURGESS DANIEL D (Reporting) CIK: 0001239650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 211134251

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations